Your browser doesn't support javascript.
loading
High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study.
Baldacci, Simon; Figeac, Martin; Antoine, Martine; Descarpentries, Clotilde; Kherrouche, Zoulika; Jamme, Philippe; Copin, Marie-Christine; Tulasne, David; Nanni, Isabelle; Beau-Faller, Michèle; Melaabi, Samia; Levallet, Guénaëlle; Quoix, Elisabeth; Moro-Sibilot, Denis; Friard, Sylvie; Missy, Pascale; Barlesi, Fabrice; Cadranel, Jacques; Cortot, Alexis B.
Affiliation
  • Baldacci S; Lille University Hospital, CHU Lille, Thoracic Oncology Department, Lille, France.
  • Figeac M; University Lille, Functional and Structural Platform, CHU Lille, Lille, France.
  • Antoine M; Department of Pathology, Hospital Tenon, AP-HP, Paris, France.
  • Descarpentries C; Department of Biochemistry and Molecular Biology, Hormonology Metabolism Nutrition Oncology, CHU Lille, Lille, France.
  • Kherrouche Z; University Lille, CNRS, Institut Pasteur de Lille, UMR 8161 - M3T - Mechanisms of Tumorigenesis and Targeted Therapies, F-59000 Lille, France.
  • Jamme P; University Lille, CNRS, Institut Pasteur de Lille, UMR 8161 - M3T - Mechanisms of Tumorigenesis and Targeted Therapies, F-59000 Lille, France.
  • Copin MC; University Lille, CHU Lille, Institute of Pathology, UMR8161 CNRS, Institute of Biology of Lille, F-59000 Lille, France.
  • Tulasne D; University Lille, CNRS, Institut Pasteur de Lille, UMR 8161 - M3T - Mechanisms of Tumorigenesis and Targeted Therapies, F-59000 Lille, France.
  • Nanni I; Department of Molecular Oncology, Assistance Publique Hôpitaux de Marseille, Marseille, France.
  • Beau-Faller M; Department of Molecular Biology, Strasbourg University Hospital, Strasbourg, France.
  • Melaabi S; Unit of Pharmacogenomics, Department of Genetics, Institut Curie, Paris, France.
  • Levallet G; Department of Pathology, CHU de Caen, Caen, France.
  • Quoix E; Department of Pneumology, Nouvel Hôpital Civil, University Hospital, Strasbourg, France.
  • Moro-Sibilot D; Department of Pneumology, Grenoble University Hospital, Grenoble, France.
  • Friard S; Pneumology Department, Foch Hospital, Suresnes, France.
  • Missy P; Clinical Research Unit, French Cooperative Thoracic Intergroup (IFCT), Paris, France.
  • Barlesi F; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations Department, Marseille, France.
  • Cadranel J; Chest Department-Thoracic Oncology Expert Center, AP-HP, Groupe Hospitalier HUEP, Hopital Tenon, Paris, France, and Sorbonne University, Paris, France.
  • Cortot AB; Lille University Hospital, CHU Lille, Thoracic Oncology Department, Lille, France. Electronic address: alexis.cortot@chru-lille.fr.
J Thorac Oncol ; 15(1): 120-124, 2020 01.
Article in En | MEDLINE | ID: mdl-31605799
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Thorac Oncol Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Thorac Oncol Year: 2020 Document type: Article Affiliation country: Country of publication: